State Street’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.9K Hold
23,872
﹤0.01% 4136
2026
Q1
$15.9K Hold
23,872
﹤0.01% 4231
2025
Q4
$15.8K Hold
23,872
﹤0.01% 4256
2025
Q3
$18.5K Hold
23,872
﹤0.01% 4252
2025
Q2
$33.9K Hold
23,872
﹤0.01% 4149
2025
Q1
$31K Hold
23,872
﹤0.01% 4154
2024
Q4
$35.1K Hold
23,872
﹤0.01% 4165
2024
Q3
$77.6K Hold
23,872
﹤0.01% 4025
2024
Q2
$56.3K Sell
23,872
-11,200
-32% -$41.7K ﹤0.01% 4119
2024
Q1
$137K Buy
+35,072
New +$103K ﹤0.01% 3963

Other funds holding COCH

State Street's COCH Position: Q2 2026 in Review

State Street held its Envoy Medical (COCH) position steady in Q2 2026 at 23,872 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4136.

State Street first reported a position in COCH in Q1 2024 and has held it in 10 quarters since. The position peaked at $137K in Q1 2024. 10 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • State Street held 23,872 shares of Envoy Medical worth $18.9K as of Q2 2026.
  • State Street left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4136 holding.
  • State Street first reported a position in Envoy Medical in Q1 2024 and has held it in 10 quarters since.
  • State Street's Envoy Medical position peaked at $137K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.